# Malaria High-Risk Populations in Namibia

> **NCT04094727** · PHASE4 · COMPLETED · sponsor: **University of California, San Francisco** · enrollment: 3302 (actual)

## Conditions studied

- Malaria

## Interventions

- **DRUG:** Presumptive treatment with Artemether-lumefantrine (AL)
- **OTHER:** Enhanced vector control

## Key facts

- **NCT ID:** NCT04094727
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-10-31
- **Primary completion:** 2020-06-30
- **Final completion:** 2020-06-30
- **Target enrollment:** 3302 (ACTUAL)
- **Last updated:** 2020-11-03

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04094727

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04094727, "Malaria High-Risk Populations in Namibia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04094727. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*